• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Heart J Cardiovasc Imaging . Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric cardiovascular m

tetano

Editor, Senior Moderator
Eur Heart J Cardiovasc Imaging


. 2021 Mar 4;jeab042.
doi: 10.1093/ehjci/jeab042. Online ahead of print.
Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric cardiovascular magnetic resonance imaging


Bing-Hua Chen[SUP] 1 [/SUP], Nan-Nan Shi[SUP] 2 [/SUP], Chong-Wen Wu[SUP] 1 [/SUP], Dong-Aolei An[SUP] 1 [/SUP], Yu-Xin Shi[SUP] 2 [/SUP], Luke D Wesemann[SUP] 3 [/SUP], Jiani Hu[SUP] 3 [/SUP], Jian-Rong Xu[SUP] 1 [/SUP], Fei Shan[SUP] 2 [/SUP], Lian-Ming Wu[SUP] 1 [/SUP]



Affiliations

Abstract

Aims: In order to determine acute cardiac involvement in patients with COVID-19, we quantitatively evaluated tissue characteristics and mechanics by non-invasive cardiac magnetic resonance (CMR) in a cohort of patients within the first 10 days of the onset of COVID symptoms.
Methods and results: Twenty-five patients with reverse transcription polymerase chain reaction confirmed COVID-19 and at least one marker of cardiac involvement [cardiac symptoms, abnormal electrocardiograph (ECG), or abnormal cardiac biomarkers] and 25 healthy age- and gender-matched control subjects were recruited to the study. Patients were divided into those with elevated (n = 8) or normal TnI (n = 17). There were significant differences in global longitudinal strain among patients who were positive and negative for hs-TnI, and controls [-12.3 (-13.3, -11.5)%, -13.1 (-14.2, -9.8)%, and -15.7 (-18.3, -12.7)%, P = 0.004]. Native myocardial T1 relaxation times in patients with positive and negative hs-TnI manifestation (1169.8 ? 12.9 and 1113.2 ? 31.2 ms) were significantly higher than the normal (1065 ? 57 ms) subjects, respectively (P < 0.001). The extracellular volume (ECV) of patients who were positive and negative for hs-TnI was higher than that of the normal controls [32 (31, 33)%, 29 (27, 30)%, and 26 (24, 27.5)%, P < 0.001]. In our study, quantitative T2 mapping in patients who were positive and negative for hs-TnI [51 (47.9, 52.8) and 48 (47, 49.4) ms] was significantly higher than the normal [42 (41, 45.2) ms] subjects (P < 0.001).
Conclusion: In patients with early-stage COVID-19, myocardial oedema, and functional abnormalities are a frequent finding, while irreversible regional injury such as necrosis may be infrequent.

Keywords: coronavirus; diagnosis; inflammation; magnetic resonance imaging.
 
Back
Top Bottom